Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study

Xiaoyu Wang,Wei Cang,Xiaomei Liu,Yu Cheng,Xirun Wan,Fengzhi Feng,Tong Ren,Jun Zhao,Fang Jiang,Hongyan Cheng,Yu Gu,Lihua Chen,Chen Li,Xiuqin Li,Junjun Yang,Xin Lu,Yang Xiang

eClinicalMedicine（2023）

引用 4|浏览15

暂无评分

摘要

The study was supported by National Natural Science Foundation of China (81971475 and 81972451), and the National High Level Hospital Clinical Research Funding (2022-PUMCH-B-083 and 2022-PUMCH-B-084).

查看译文

关键词

gestational trophoblastic neoplasia,chemotherapy,high-risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要